the Chair of the Board, shall be a member. The Executive Committee will have all the authority of the Board of Directors except as otherwise provided by Section 712 of the Business Corporation Law or other applicable statutes. Any other committees will have such authority as the Board of Directors may provide. The Board of Directors may designate one or more directors as alternate members of any committee to replace absent members. Subject to Article II, Section 14, the members of all committees shall be selected by and removed by the Board of Directors. Such committees may meet at stated times or, in accordance with their charters, upon notice to all the members of the committee. Each committee shall keep regular minutes of its proceedings and report the same to the Board of Directors when required.
SECTION 12 Removal. Any director may be removed with cause by the affirmative vote of at least two-thirds of the entire Board of Directors or with or without cause by vote of the shareholders at a regular or special meeting, subject to the provisions of the Business Corporation Law.
SECTION 13 Compensation. The directors and the members of any committee of the Board of Directors of the Corporation shall be entitled to be reimbursed for any expenses, including all travel expenses, incurred by them on account of their attendance at any regular or special meeting of the Board of Directors or of such committee, and the Board of Directors may at any time or from time to time by resolution provide that the Corporation shall pay each such director or member of such committee such compensation for his or her services as may be specified in such resolution. Nothing in this Section 13 shall be construed to preclude any director from serving the Corporation in any other capacity and receiving compensation therefore.
SECTION 14 Special Governance Matters.
(a) Board Composition. As of the Effective Time on February 1, 2021, the Board of Directors of the Corporation consisted of (i) six (6) directors designated by the board of directors of DuPont de Nemours, Inc. (“DuPont”) (collectively, the “DuPont Designees”), and (ii) seven (7) directors designated by the Board of Directors as of immediately prior to the Effective Time and who were members of the Board of Directors immediately prior to the Effective Time (collectively, the “IFF Designees”). For purposes of this Article II in these By-Laws, the term “Effective Time” shall have the meaning set forth in that certain Agreement and Plan of Merger (the “Merger Agreement”) dated as of December 15, 2019, by and among DuPont, Nutrition & Biosciences, Inc., the Corporation, and Neptune Merger Sub I Inc.
(b) Nomination. The Board of Directors shall nominate for election to the Board of Directors at the Corporation’s 2022 annual meeting (i) the six (6) DuPont Designees (or any replacements thereof pursuant to Article II, Section 14(d)) and (ii) six (6) IFF Designees (or any replacements thereof pursuant to Article II, Section 14(d)). The Board of Directors may nominate for election at such meeting more than twelve (12) directors in total, provided that the nomination of any additional directors shall require the approval by (i) the affirmative vote of a majority of the IFF Designees and/or Continuing IFF Designees, as applicable, then in office and (ii) the affirmative vote of a majority of the DuPont Designees and/or Continuing DuPont Designees, as applicable, then in office.
(c) Vacancies. Until the Corporation’s 2022 annual meeting:
(i) if there is a vacancy created by cessation of service of any DuPont Designee (whether as a result of illness, death, resignation, removal or any other reason, but in each case, except as provided in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote of a majority of the remaining DuPont Designees then in office, even if less than a quorum, or by a sole remaining DuPont Designee (any such replacement, a “Continuing DuPont Designee”); and if there is a vacancy created by cessation of service of any Continuing DuPont Designee (whether as a result of illness, death, resignation, removal or any other reason, but in each case, except as provided in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote of a majority of the remaining DuPont Designees and/or Continuing DuPont Designee, as applicable, then in office, even if less than a quorum, or by a sole remaining DuPont Designee and/or Continuing DuPont Designee, as applicable;
(ii) if there is a vacancy created by cessation of service of any IFF Designee (whether as a result of illness, death, resignation, removal or any other reason, but in each case, except as provided in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote of a majority of the
16